Form D · Biotechnology

Prothena Corp plc

Dun Laoghaire, Co. Dublin, L2 · CIK 0001559053

Offering snapshot reported Mar 29, 2018 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 21, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 29, 2018Initial$49,999,997No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-308886

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Mar 29, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard T. Collier Director
Shane M. Cooke Director
Lars G. Eckman, M.D., Ph.D. Director
Anders O. Harfstrand, M.D., Ph.D. Director
Christopher S. Henney, Ph.D., D.Sc. Director
Arthur W. Homan Executive
Carol D. Karp Executive
Gene G. Kinney, Ph.D. Director, Executive
Tran B. Nguyen Executive
Tara Nickerson, Ph.D. Executive
Dennis J. Selkoe Director
Karin L. Walker Executive
Wagner M. Zago, Ph.D. Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Adelphi Plaza Upper George's Street
Dun Laoghaire, Co. Dublin, L2, A96 T927